pI: 9.8406 |
Length (AA): 839 |
MW (Da): 98110 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
141 | 619 | 2b9s (A) | 27 | 455 | 42.00 | 0 | 1 | 0.76 | 0.12 |
154 | 382 | 1ois () | 143 | 363 | 41.00 | 0 | 1 | 0.71 | -0.28 |
316 | 638 | 2f4q (A) | 2 | 309 | 14.00 | 0 | 0.82 | -0.03 | 0.7 |
787 | 839 | 2b9s (B) | 211 | 262 | 54.00 | 0.0000000072 | 0.62 | 0.78 | -1.32 |
140 | 839 | 1k4t (A) | 201 | 765 | 43.00 | 0 | 1 | 0.972727 | 0.97 |
570 | 751 | 4uos (A) | 1 | 183 | 11.00 | 0.036 | 0.08 | 0.390325 | -1.2 |
787 | 839 | 2b9s (B) | 211 | 262 | 54.00 | 0.00000061 | 0.57 | 0.62677 | 0.17 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Male Gametocyte. | PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, merozoite, Oocyst, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, Female Gametocyte. | Otto TD Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Sporozoite. | Zanghi G |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_127702)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G55310 | DNA topoisomerase 1 beta |
Arabidopsis thaliana | AT5G55300 | DNA topoisomerase 1 |
Babesia bovis | BBOV_II007450 | DNA topoisomerase |
Brugia malayi | Bm1_41680 | DNA topoisomerase I |
Candida albicans | CaO19.96 | likely DNA topoisomerase I similar to S. cerevisiae TOP1 (YOL006C) |
Candida albicans | CaO19.7742 | likely DNA topoisomerase I similar to S. cerevisiae TOP1 (YOL006C) |
Caenorhabditis elegans | CELE_M01E5.5 | Protein TOP-1, isoform A |
Cryptosporidium hominis | Chro.70373 | DNA topoisomerase I |
Cryptosporidium parvum | cgd7_3350 | eukaryotic DNA topoisomerase I |
Dictyostelium discoideum | DDB_G0283205 | DNA topoisomerase I |
Drosophila melanogaster | Dmel_CG6146 | Topoisomerase 1 |
Echinococcus granulosus | EgrG_000700500 | DNA topoisomerase 1 |
Echinococcus multilocularis | EmuJ_000700500 | DNA topoisomerase 1 |
Homo sapiens | ENSG00000198900 | topoisomerase (DNA) I |
Homo sapiens | ENSG00000184428 | topoisomerase (DNA) I, mitochondrial |
Leishmania braziliensis | LbrM.20.3020 | DNA topoisomerase IB, large subunit |
Leishmania donovani | LdBPK_343220.1 | DNA topoisomerase IB, large subunit |
Leishmania infantum | LinJ.34.3220 | DNA topoisomerase IB, large subunit |
Leishmania major | LmjF.34.3440 | DNA topoisomerase IB, large subunit |
Leishmania mexicana | LmxM.33.3440 | DNA topoisomerase IB, large subunit |
Loa Loa (eye worm) | LOAG_09811 | DNA topoisomerase I |
Mus musculus | ENSMUSG00000070544 | topoisomerase (DNA) I |
Mus musculus | ENSMUSG00000000934 | DNA topoisomerase 1, mitochondrial |
Neospora caninum | NCLIV_049500 | hypothetical protein |
Oryza sativa | 4344685 | Os08g0154600 |
Plasmodium berghei | PBANKA_1110100 | topoisomerase I, putative |
Plasmodium falciparum | PF3D7_0510500 | topoisomerase I |
Plasmodium knowlesi | PKNH_1023100 | topoisomerase I, putative |
Plasmodium vivax | PVX_098085 | topoisomerase I, putative |
Plasmodium yoelii | PY05226 | Eukaryotic DNA topoisomerase I, DNA binding, putative |
Saccharomyces cerevisiae | YOL006C | DNA topoisomerase 1 |
Schistosoma japonicum | Sjp_0092890 | ko:K03163 DNA topoisomerase I, putative |
Schistosoma japonicum | Sjp_0317930 | IPR011010,DNA breaking-rejoining enzyme, catalytic core,domain-containing |
Schistosoma mansoni | Smp_033050.2 | DNA topoisomerase type I |
Schistosoma mansoni | Smp_033050.3 | DNA topoisomerase type I |
Schistosoma mansoni | Smp_033050.1 | DNA topoisomerase type I |
Schmidtea mediterranea | mk4.009207.00 | DNA topoisomerase 1 |
Trypanosoma brucei gambiense | Tbg972.4.1160 | DNA topoisomerase IB, large subunit, putative |
Trypanosoma brucei | Tb927.4.1330 | DNA topoisomerase IB, large subunit |
Trypanosoma cruzi | TcCLB.508693.20 | DNA topoisomerase IB, large subunit, putative |
Toxoplasma gondii | TGME49_234360 | DNA topoisomerase I, putative |
Theileria parva | TP02_0198 | DNA topoisomerase I, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.1330 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.1330 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.1330 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.4.1330 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_M01E5.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_M01E5.5 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_M01E5.5 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_M01E5.5 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_234360 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium berghei | 5550 |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 3011062 9515582 | |
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium falciparum | 5550 |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 3011062 9515582 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 1
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Mus musculus | topoisomerase (DNA) I | Compounds | References |
Trypanosoma brucei | DNA topoisomerase IB, large subunit | Compounds | References |
Leishmania major | DNA topoisomerase IB, large subunit | Compounds | References |
Saccharomyces cerevisiae | DNA topoisomerase 1 | Compounds | References |
Trypanosoma cruzi | DNA topoisomerase IB, large subunit, putative | Compounds | References |
Chlorocebus aethiops | DNA topoisomerase 1 | Compounds | References |
Homo sapiens | topoisomerase (DNA) I | Compounds | References |
Rattus norvegicus | DNA topoisomerase 1 | Compounds | References |
8 literature references were collected for this gene.